“…Epilepsy, the fourth most frequent neurological disorder, affects more than sixty million people globally (Singh, 2015;Singh & Karkare, 2017;Trinka et al, 2015;Singh, He, McNamara, & Danzer, 2013;Singh, LaSarge, An, McAuliffe, & Danzer, 2015). The social stigma linked with this condition often primes depression and is frequently associated with a decline in the quality of life (Benson et al, 2016;Hester et al, 2016;Luna et al, 2017). The problem is exacerbated by the confusion of focusing research efforts on multiple anti-epileptic drugs (AEDs), some of which show mixed results in the refractory epileptic populations (Ahmad et al, 2017;de Biase, Valente, Gigli, & Merlino, 2017;Nolan, Marson, Weston, & Tudur Smith, 2015;Pellock et al, 2017;Turner & Perry, 2017).…”